Back to Agenda
Session 4: Towards the Integration of Patient Preferences into Decision Making
Session Chair(s)
Bennett Levitan, MD
Executive Director, Benefit-Risk Assessment / Epidemiology, Johnson & Johnson, United States
Session 4: Towards the Integration of Patient Preferences into Decision Making
Speaker(s)
Applications of Patient Preference Studies in Regulatory Decisions
Michelle Tarver, MD, PhD
Deputy Center Director for Transformation, CDRH, FDA, United States
Applications of Patient Preference Studies in Regulatory Decisions
Francesco Pignatti, MD
Scientific Adviser for Oncology, European Medicines Agency, Netherlands
Applications of Patient Preference Studies in HTA Decisions
Ana Margarida Oliveira
Pharmacist, Health Technology Assessment Department, Infarmed, Portugal
Applications of Patient Preference Studies in HTA Decisions
Irina Cleemput, PhD
Scientific Programme Director, Belgian Health Care Knowledge Centre (KCE), Belgium
Applications of Patient Preference Studies in Industry Decisions
Brett Hauber, PhD, MA
Patient Preference Evidence Generation Team Lead, Pfizer, United States
Have an account?